POMDOCTOR Ltd Files 6-K for H1 2025 Results
Ticker: POM · Form: 6-K · Filed: Dec 3, 2025 · CIK: 1877971
| Field | Detail |
|---|---|
| Company | Pomdoctor Ltd (POM) |
| Form Type | 6-K |
| Filed Date | Dec 3, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, foreign-private-issuer, 6-K
TL;DR
POMDOCTOR Ltd dropped its H1 2025 financials via 6-K.
AI Summary
POMDOCTOR Ltd, a foreign private issuer, filed a Form 6-K on December 3, 2025, to report its unaudited financial results for the first half of fiscal year 2025. The company is incorporated in E9 and its principal executive office is located in Guangzhou, People's Republic of China.
Why It Matters
This filing provides investors with an update on POMDOCTOR Ltd's financial performance for the first half of fiscal year 2025, offering insights into the company's operational status.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing (6-K) and does not contain new material events or significant financial changes.
Key Players & Entities
- POMDOCTOR Ltd (company) — Registrant
- 0001213900-25-117830 (filing_id) — Accession Number
- 20251203 (date) — Filing Date
- Guangzhou (location) — Principal Executive Office Location
- People's Republic of China (country) — Company Location
FAQ
What type of report is POMDOCTOR Ltd filing?
POMDOCTOR Ltd is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What period do the financial results in the filing cover?
The filing announces the first half of fiscal year 2025 unaudited financial results.
Where is POMDOCTOR Ltd's principal executive office located?
The principal executive office is located at Yongxu Industrial Park, No.19-23 Hejing Road, Dongsha Street, Liwan District, Guangzhou, 510000, People's Republic of China.
Does POMDOCTOR Ltd file annual reports under Form 20-F or 40-F?
POMDOCTOR Ltd indicates it files annual reports under Form 20-F.
What is the filing date of this Form 6-K?
The filing date is December 3, 2025.
Filing Stats: 169 words · 1 min read · ~1 pages · Grade level 13 · Accepted 2025-12-03 16:15:30
Filing Documents
- ea0268059-6k_pomdoc.htm (6-K) — 9KB
- ea026805901ex99-1_pomdoc.htm (EX-99.1) — 151KB
- 0001213900-25-117830.txt ( ) — 161KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-42749 POMDOCTOR LIMITED (Exact name of registrant as specified in its charter) Yongxu Industrial Park No.19-23 Hejing Road, Dongsha Street Liwan District, Guangzhou 510000 People’s Republic of China (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit No. Description 99.1 POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. POMDOCTOR LIMITED By: /s/ Zhenyang Shi Name: Zhenyang Shi Title: Chairman and Chief Executive Officer Date: December 3, 2025 2